Log in to save to my catalogue

Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s...

Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_98c632aad8d54fd8a4064f37087b4dc8

Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a analysis

About this item

Full title

Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a analysis

Publisher

SAGE Publishing

Journal title

Therapeutic advances in gastroenterology, 2019-10, Vol.12

Language

English

Formats

Publication information

Publisher

SAGE Publishing

More information

Scope and Contents

Contents

Background: Matrix metalloproteinase-9 (MMP-9) is a novel marker of intestinal inflammation. The aim of this study was to assess if serum MMP-9 levels predict clinical flare in patients with quiescent Crohn’s disease (CD). Methods: This study was a post hoc analysis of a prospective observational study in which quiescent CD patients were included a...

Alternative Titles

Full title

Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_98c632aad8d54fd8a4064f37087b4dc8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_98c632aad8d54fd8a4064f37087b4dc8

Other Identifiers

E-ISSN

1756-2848

DOI

10.1177/1756284819881590

How to access this item